Searchable abstracts of presentations at key conferences in endocrinology

ea0090p92 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

A study to evaluate clinical and metabolic profile in a type 1 diabetes cohort receiving dpp4 inhibitor plus SGLT2 inhibitor compared to either drug alone as an adjuvant therapy

Dev K Chethan , Kumar Sethi Bipin

Introduction: There is always been a need for safe and effective adjuvant therapy in type 1 Diabetes not just for glycemic control but also for cardio-renal benefits.Objectives: To evaluate whether addition of DPP-4 inhibitors reduces the ketogenic potential of SGLT2i when used as an adjuvant therapy in type 1 Diabetes.Materials & Methods: 20 type 1 Diabetes subjects above 18 years of age with poorly controlled glycemia (HbA1c ...

ea0090p360 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Consensus Towards Reassessing Gliclazide for the Place in Therapy Based on Novel Cluster Classification of Diabetes

Sethi Bipin , A G Unnikrishnan , Ayyagari Usha , Narayanan Prem , Acharya Raviraj , Balachandran Karthik , Reena Adlyne , Lathia Tejal

Introduction: A novel classification of adult onset DM into five subgroups: Severe Autoimmune Diabetes (SAID); Severe Insulin-Deficient Diabetes (SIDD); Severe Insulin-Resistant Diabetes (SIRD); Mild Obesity-Related Diabetes (MOD); and Mild Age-Related Diabetes (MARD) has been postulated. We aim to formulate a consensus statement towards reassessing gliclazide use based on cluster classification of diabetes mellitusMethods: A virtual collaborative educat...